NASDAQ: PYXS
Pyxis Oncology Inc Stock Ownership - Who owns Pyxis Oncology?

Insider buying vs selling

Have Pyxis Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jakob DupontDirector2026-06-3035,000$1.60
$56.00kBuy
Jakob DupontDirector2026-06-3035,000$3.06
$107.10kSell

1 of 1

PYXS insiders have bought as... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PYXS insiders and whales buy or sell their stock.

PYXS Shareholders

What type of owners hold Pyxis Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gordonmd Global Investments LP15.82%10,024,909$29.17MInsider
Pfizer Inc11.10%7,032,770$20.47MInsider
Pfizer Inc11.10%7,032,770$20.47MInstitution
Laurion Capital Management LP7.89%4,997,333$14.54MInstitution
Gordonmd Global Investments LP6.51%4,121,870$11.99MInstitution
Barclays PLC5.49%3,477,975$10.12MInsider
Pamela Ann Connealy5.41%3,425,179$9.97MInsider
Bayer World Investments Bv4.33%2,742,338$7.98MInsider
Lara Sullivan3.79%2,403,882$7.00MInsider
Vanguard Capital Management LLC3.21%2,033,510$5.92MInstitution

1 of 3

PYXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PYXS43.52%52.84%Net BuyingNet Buying
LENZ52.97%47.03%Net Selling
DTIL36.73%63.27%Net Selling
VYGR53.04%46.96%Net Selling
ACOG48.37%33.41%Net BuyingNet Buying

Pyxis Oncology Stock Ownership FAQ

Who owns Pyxis Oncology?

Pyxis Oncology (NASDAQ: PYXS) is owned by 43.52% institutional shareholders, 52.84% Pyxis Oncology insiders, and 3.65% retail investors. Gordonmd Global Investments LP is the largest individual Pyxis Oncology shareholder, owning 10.02M shares representing 15.82% of the company. Gordonmd Global Investments LP's Pyxis Oncology shares are currently valued at $29.17M.

If you're new to stock investing, here's how to buy Pyxis Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.